Literature DB >> 11326312

Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues.

E Hiyama1, K Hiyama, T Yokoyama, J W Shay.   

Abstract

We examined human telomerase reverse transcriptase (hTERT) protein distribution by immunohistochemistry in cultured cells and tissue sections. Cells with telomerase activity had nuclear positive signals whereas cells without telomerase activity did not. In most normal epithelial tissues, hTERT expression was prominent in the early proliferative descendent progenitors cells. In cancers with high telomerase activity, hTERT expression was detected in almost all neoplastic cells and correlated with telomerase activity levels, whereas cancers with low telomerase activity had fewer hTERT-positive cancer cells. In pediatric neuroblastomas with a favorable outcome, both the percentage of positive cells and the signal intensities of each hTERT-expressing cell decreased. These studies indicate that detection of telomerase at the cellular level is achievable and may have utility in cancer diagnostics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326312      PMCID: PMC1505023          DOI: 10.1038/sj.neo.7900134

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  31 in total

1.  Telomerase activity in ductal carcinoma in situ and invasive breast cancer.

Authors:  C B Umbricht; M E Sherman; J Dome; L A Carey; J Marks; N Kim; S Sukumar
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

2.  Telomerase activity in human germline and embryonic tissues and cells.

Authors:  W E Wright; M A Piatyszek; W E Rainey; W Byrd; J W Shay
Journal:  Dev Genet       Date:  1996

3.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

4.  Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).

Authors:  M Wick; D Zubov; G Hagen
Journal:  Gene       Date:  1999-05-17       Impact factor: 3.688

Review 5.  Aging and cancer: are telomeres and telomerase the connection?

Authors:  J W Shay
Journal:  Mol Med Today       Date:  1995-11

6.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Telomerase activity is detected in pancreatic cancer but not in benign tumors.

Authors:  E Hiyama; T Kodama; K Shinbara; T Iwao; M Itoh; K Hiyama; J W Shay; Y Matsuura; T Yokoyama
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

8.  Correlating telomerase activity levels with human neuroblastoma outcomes.

Authors:  E Hiyama; K Hiyama; T Yokoyama; Y Matsuura; M A Piatyszek; J W Shay
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

9.  Telomerase activity in small-cell and non-small-cell lung cancers.

Authors:  K Hiyama; E Hiyama; S Ishioka; M Yamakido; K Inai; A F Gazdar; M A Piatyszek; J W Shay
Journal:  J Natl Cancer Inst       Date:  1995-06-21       Impact factor: 13.506

10.  Detection of telomerase activity in malignant and nonmalignant skin conditions.

Authors:  R S Taylor; R D Ramirez; M Ogoshi; M Chaffins; M A Piatyszek; J W Shay
Journal:  J Invest Dermatol       Date:  1996-04       Impact factor: 8.551

View more
  32 in total

1.  Integrated nanosensors to determine levels and functional activity of human telomerase.

Authors:  J Manuel Perez; Jan Grimm; Lee Josephson; Ralph Weissleder
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

2.  Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomes.

Authors:  Arnout G Schepers; Robert Vries; Maaike van den Born; Marc van de Wetering; Hans Clevers
Journal:  EMBO J       Date:  2011-02-04       Impact factor: 11.598

3.  Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor.

Authors:  Gulden Diniz; Safiye Aktas; Aysen Turedi; Gunyuz Temir; Ragip Ortac; Canan Vergin
Journal:  Tumour Biol       Date:  2011-05-08

4.  Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase.

Authors:  Satoru Kyo; Kenkichi Masutomi; Yoshiko Maida; Taro Kanaya; Noriyuki Yatabe; Mitsuhiro Nakamura; Masaaki Tanaka; Mitsuko Takarada; Isamu Sugawara; Seishi Murakami; Takahiro Taira; Masaki Inoue
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

5.  The effect of phosphorylated Akt inhibition on posterior capsule opacification in an ex vivo canine model.

Authors:  Heather L Chandler; Terah R Webb; Curtis A Barden; Mirunalni Thangavelu; Samuel K Kulp; Ching-Shih Chen; Carmen M H Colitz
Journal:  Mol Vis       Date:  2010-10-29       Impact factor: 2.367

6.  Immunohistochemical localization of hTERT protein in human tissues.

Authors:  Pu Yan; Jean Benhattar; Walter Seelentag; Jean-Christophe Stehle; Fred T Bosman
Journal:  Histochem Cell Biol       Date:  2004-05-07       Impact factor: 4.304

7.  Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors.

Authors:  Robert L Ochs; Jeffrey Fensterer; N Paul Ohori; Alan Wells; Michael Gabrin; Lisa D George; Paul Kornblith
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jan-Feb       Impact factor: 2.416

8.  Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Yasushi Hashimoto; Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo; Hiroki Ohge; Emi Fukuda; Fumio Shimamoto; Taijiro Sueda; Eiso Hiyama
Journal:  J Gastrointest Surg       Date:  2008-01       Impact factor: 3.452

9.  Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.

Authors:  Su-Yang Liu; Nancy M Joseph; Ajay Ravindranathan; Bradley A Stohr; Nancy Y Greenland; Poonam Vohra; Elizabeth Hosfield; Iwei Yeh; Eric Talevich; Courtney Onodera; Jessica A Van Ziffle; James P Grenert; Boris C Bastian; Yunn-Yi Chen; Gregor Krings
Journal:  Mod Pathol       Date:  2016-06-03       Impact factor: 7.842

10.  Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene.

Authors:  Lynda Li Song; Larissa Ponomareva; Hui Shen; Xin Duan; Fatouma Alimirah; Divaker Choubey
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.